Sirius: A Resource for Analyzing Drug-Disease Relationships for Drug Repositioning
- 9 May 2019
- book chapter
- Published by Springer Nature
- p. 235-244
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A standard database for drug repositioningScientific Data, 2017
- Innovation in the pharmaceutical industry: New estimates of R&D costsJournal of Health Economics, 2016
- STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity dataNucleic Acids Research, 2015
- 2013 FDA drug approvalsNature Reviews Drug Discovery, 2014
- Network-Based Drug Ranking and Repositioning with Respect to DrugBank Therapeutic CategoriesIEEE/ACM Transactions on Computational Biology and Bioinformatics, 2013
- Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drugBMC Systems Biology, 2012
- Drug repositioning through incomplete bi-cliques in an integrated drug–target–disease networkIntegrative Biology, 2012
- The productivity crisis in pharmaceutical R&DNature Reviews Drug Discovery, 2011
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003